In this interview, Dr Emma Hodcroft, a Molecular Epidemiologist from the University of Basel, explains how disease modelling works and the impact that limitations have had on our reactions to the COVID-19 outbreak.
Cell CultureDiagnosticsDrug DiscoveryGenomics